Trends in mortality related to pulmonary embolism in the DACH countries
© 2021. The Author(s)..
BACKGROUND: Pulmonary embolism (PE)-related mortality is decreasing worldwide.
AIM: Little is known about the burden imposed by pulmonary embolism for Germany, Austria and Switzerland (DACH countries).
MATERIALS AND METHODS: We aimed to assess pulmonary embolism-related mortality and time trends for the DACH countries based on data from the WHO Mortality Database. Deaths were considered pulmonary embolism-related if the International Classification of Disease-10 code for acute pulmonary embolism or any code for deep or superficial vein thrombosis was listed as the primary cause of death.
RESULTS: Between 2000 and 2015, age-standardized annual pulmonary embolism-related mortality rates decreased linearly from 15.6 to 7.8 deaths per 1000 population. In the 5‑year period between 2012 and 2016, an average of 9127 pulmonary embolism-related deaths occurred annually in the DACH countries with a population of 98,273,329. Interestingly, pulmonary embolism-related mortality rates were considerably higher among women aged 15-55 years compared to age-matched men.
CONCLUSION: The observed decreasing trends in pulmonary embolism-related mortality might reflect improved management of the disease including new treatment options as well as advances in imaging technologies. However, pulmonary embolism remains a substantial contributor to total mortality, especially among women aged 15-55 years. For this reason, campaigns to increase physician and public awareness are urgently required to further improve the management and treatment of this preventable thrombotic disorder, which still remains the leading preventable cause of death.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
|---|---|
| Enthalten in: |
Medizinische Klinik, Intensivmedizin und Notfallmedizin - 117(2022), 6 vom: 14. Sept., Seite 428-438 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Sterblichkeit der Lungenembolie in der DACH-Region |
|---|
| Beteiligte Personen: |
Hobohm, Lukas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1,2-cyclohexanediamine |
|---|
| Anmerkungen: |
Date Completed 09.09.2022 Date Revised 10.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00063-021-00854-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329742027 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329742027 | ||
| 003 | DE-627 | ||
| 005 | 20231226203459.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00063-021-00854-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329742027 | ||
| 035 | |a (NLM)34430980 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Hobohm, Lukas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Trends in mortality related to pulmonary embolism in the DACH countries |
| 246 | 3 | 3 | |a Sterblichkeit der Lungenembolie in der DACH-Region |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.09.2022 | ||
| 500 | |a Date Revised 10.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a BACKGROUND: Pulmonary embolism (PE)-related mortality is decreasing worldwide | ||
| 520 | |a AIM: Little is known about the burden imposed by pulmonary embolism for Germany, Austria and Switzerland (DACH countries) | ||
| 520 | |a MATERIALS AND METHODS: We aimed to assess pulmonary embolism-related mortality and time trends for the DACH countries based on data from the WHO Mortality Database. Deaths were considered pulmonary embolism-related if the International Classification of Disease-10 code for acute pulmonary embolism or any code for deep or superficial vein thrombosis was listed as the primary cause of death | ||
| 520 | |a RESULTS: Between 2000 and 2015, age-standardized annual pulmonary embolism-related mortality rates decreased linearly from 15.6 to 7.8 deaths per 1000 population. In the 5‑year period between 2012 and 2016, an average of 9127 pulmonary embolism-related deaths occurred annually in the DACH countries with a population of 98,273,329. Interestingly, pulmonary embolism-related mortality rates were considerably higher among women aged 15-55 years compared to age-matched men | ||
| 520 | |a CONCLUSION: The observed decreasing trends in pulmonary embolism-related mortality might reflect improved management of the disease including new treatment options as well as advances in imaging technologies. However, pulmonary embolism remains a substantial contributor to total mortality, especially among women aged 15-55 years. For this reason, campaigns to increase physician and public awareness are urgently required to further improve the management and treatment of this preventable thrombotic disorder, which still remains the leading preventable cause of death | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Austria | |
| 650 | 4 | |a Germany | |
| 650 | 4 | |a Prevention | |
| 650 | 4 | |a Switzerland | |
| 650 | 4 | |a Treatment | |
| 650 | 7 | |a Cyclohexylamines |2 NLM | |
| 650 | 7 | |a 1,2-cyclohexanediamine |2 NLM | |
| 650 | 7 | |a C82TX76BHH |2 NLM | |
| 700 | 1 | |a Sebastian, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Valerio, Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudpour, Seyed Hamidreza |e verfasserin |4 aut | |
| 700 | 1 | |a Vatsakis, Georgios |e verfasserin |4 aut | |
| 700 | 1 | |a Johner, Fabian |e verfasserin |4 aut | |
| 700 | 1 | |a Keller, Karsten |e verfasserin |4 aut | |
| 700 | 1 | |a Münzel, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Kucher, Nils |e verfasserin |4 aut | |
| 700 | 1 | |a Konstantinides, Stavros V |e verfasserin |4 aut | |
| 700 | 1 | |a Barco, Stefano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medizinische Klinik, Intensivmedizin und Notfallmedizin |d 2012 |g 117(2022), 6 vom: 14. Sept., Seite 428-438 |w (DE-627)NLM216019842 |x 2193-6226 |7 nnns |
| 773 | 1 | 8 | |g volume:117 |g year:2022 |g number:6 |g day:14 |g month:09 |g pages:428-438 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00063-021-00854-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 117 |j 2022 |e 6 |b 14 |c 09 |h 428-438 | ||